NO941351L - Peroralt leveringssystem for legemidler - Google Patents
Peroralt leveringssystem for legemidlerInfo
- Publication number
- NO941351L NO941351L NO941351A NO941351A NO941351L NO 941351 L NO941351 L NO 941351L NO 941351 A NO941351 A NO 941351A NO 941351 A NO941351 A NO 941351A NO 941351 L NO941351 L NO 941351L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- therapeutic agent
- reservoir
- ionized
- date
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
- Treatment Of Sludge (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919121964A GB9121964D0 (en) | 1991-10-16 | 1991-10-16 | Peroral drug delivery system |
GB919123372A GB9123372D0 (en) | 1991-11-04 | 1991-11-04 | Peroral drug delivery system |
PCT/FI1992/000274 WO1993007858A1 (en) | 1991-10-16 | 1992-10-15 | Peroral drug delivery system |
Publications (3)
Publication Number | Publication Date |
---|---|
NO941351L true NO941351L (no) | 1994-04-14 |
NO941351D0 NO941351D0 (no) | 1994-04-14 |
NO307125B1 NO307125B1 (no) | 2000-02-14 |
Family
ID=26299700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO941351A NO307125B1 (no) | 1991-10-16 | 1994-04-14 | Peroralt leveringssystem for legemidler |
Country Status (9)
Country | Link |
---|---|
US (1) | US5518737A (no) |
EP (1) | EP0608306B1 (no) |
JP (1) | JPH07500110A (no) |
AT (1) | ATE135203T1 (no) |
AU (1) | AU661726B2 (no) |
CA (1) | CA2120748A1 (no) |
DE (1) | DE69209083T2 (no) |
NO (1) | NO307125B1 (no) |
WO (1) | WO1993007858A1 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2290964A (en) * | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
DE10000823A1 (de) * | 2000-01-12 | 2001-07-19 | Hartwin Hobler | Einbringen von Gasen in eine Körperflüssigkeit |
US7803148B2 (en) * | 2006-06-09 | 2010-09-28 | Neurosystec Corporation | Flow-induced delivery from a drug mass |
US20080152694A1 (en) * | 2006-07-20 | 2008-06-26 | Neurosystec Corporation | Devices, Systems and Methods for Ophthalmic Drug Delivery |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
US4756710A (en) * | 1985-04-05 | 1988-07-12 | Merck & Co., Inc. | pH-Mediated drug delivery system |
IT1204914B (it) * | 1987-03-06 | 1989-03-10 | Bonapace & C Spa | Procedimento pe la protezione di sostanze poco stabili con miscele polimeriche e processi per la loro applicazione |
US4795644A (en) * | 1987-08-03 | 1989-01-03 | Merck & Co., Inc. | Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins |
US4781924A (en) * | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
JP2827287B2 (ja) * | 1988-07-05 | 1998-11-25 | 武田薬品工業株式会社 | 水溶性薬物含有徐放型マイクロカプセル |
SE509029C2 (sv) * | 1988-08-16 | 1998-11-30 | Ss Pharmaceutical Co | Långtidsverkande diklofenak-natriumpreparat |
-
1992
- 1992-10-15 JP JP5507469A patent/JPH07500110A/ja active Pending
- 1992-10-15 WO PCT/FI1992/000274 patent/WO1993007858A1/en active IP Right Grant
- 1992-10-15 AT AT92921464T patent/ATE135203T1/de not_active IP Right Cessation
- 1992-10-15 DE DE69209083T patent/DE69209083T2/de not_active Expired - Fee Related
- 1992-10-15 AU AU27732/92A patent/AU661726B2/en not_active Ceased
- 1992-10-15 US US08/211,292 patent/US5518737A/en not_active Expired - Fee Related
- 1992-10-15 CA CA002120748A patent/CA2120748A1/en not_active Abandoned
- 1992-10-15 EP EP92921464A patent/EP0608306B1/en not_active Expired - Lifetime
-
1994
- 1994-04-14 NO NO941351A patent/NO307125B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH07500110A (ja) | 1995-01-05 |
AU2773292A (en) | 1993-05-21 |
NO307125B1 (no) | 2000-02-14 |
DE69209083T2 (de) | 1996-08-14 |
ATE135203T1 (de) | 1996-03-15 |
US5518737A (en) | 1996-05-21 |
WO1993007858A1 (en) | 1993-04-29 |
AU661726B2 (en) | 1995-08-03 |
EP0608306A1 (en) | 1994-08-03 |
DE69209083D1 (de) | 1996-04-18 |
CA2120748A1 (en) | 1993-04-29 |
NO941351D0 (no) | 1994-04-14 |
EP0608306B1 (en) | 1996-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE178485T1 (de) | Transdermales arzneistoff-abgabesystem | |
ES2007100A6 (es) | Procedimiento para la obtencion de un sistema terapeutico oral a base de carbamazepina. | |
ATE260646T1 (de) | Schnell zerfallende orale dosierungsform | |
TW347339B (en) | Oral delivery of discrete units | |
ES2172239T3 (es) | Sistema osmotico de liberacion de farmacos. | |
NO20011471L (no) | Nye orale vedvarende frigivelsesformuleringer | |
MY122081A (en) | Sustained delivery of leuprolide using an implantable system | |
TR199700930T2 (xx) | Ereksiyon bozuklu�unu �nlemek i�in y�ntem ve kit. | |
ES2053339T3 (es) | Dispositivo dispensador conteniendo un medio hidrofobo. | |
DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
ATE291901T1 (de) | Neue omeprazole und (s)-omeprazole zusammensetzung | |
NO951996D0 (no) | Leveringsinnretning med innkapslede eksipienser | |
IE882898L (en) | Solubility modulated drug delivery device | |
WO2000013662A8 (en) | Medicated chewing gum delivery system for nicotine | |
NO307125B1 (no) | Peroralt leveringssystem for legemidler | |
DE59910944D1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
KR880005944A (ko) | 삼투성 연속 분배 경구용 전달 시스템 | |
SE9700617D0 (sv) | New composition | |
MY124346A (en) | Medicated chewing gum delivery system for nicotine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2002 |